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Background: The Oxford Cognitive Screen (OCS) was recently developed with the aim 
of describing the cognitive deficits after stroke. The scale consists of 10 tasks encom-
passing five cognitive domains: attention and executive function, language, memory, 
number processing, and praxis. OCS was devised to be inclusive and un-confounded by 
aphasia and neglect. As such, it may have a greater potential to be informative on stroke 
cognitive deficits of widely used instruments, such as the Mini-Mental State Examination 
(MMSE) or the Montreal Cognitive Assessment, which were originally devised for 
demented patients.
Objective: The present study compared the OCS with the MMSE with regards to their 
ability to detect cognitive impairments post-stroke. We further aimed to examine perfor-
mance on the OCS as a function of subtypes of cerebral infarction and clinical severity.
Methods: 325 first stroke patients were consecutively enrolled in the study over a 
9-month period. The OCS and MMSE, as well as the Bamford classification and NIHSS, 
were given according to standard procedures.
results: About a third of patients (35.3%) had a performance lower than the cutoff (<22) 
on the MMSE, whereas 91.6% were impaired in at least one OCS domain, indicating 
higher incidences of impairment for the OCS. More than 80% of patients showed an 
impairment in two or more cognitive domains of the OCS. Using the MMSE as a stan-
dard of clinical practice, the comparative sensitivity of OCS was 100%. Out of the 208 
patients with normal MMSE performance 180 showed impaired performance in at least 
one domain of the OCS. The discrepancy between OCS and MMSE was particularly 
strong for patients with milder strokes. As for subtypes of cerebral infarction, fewer 
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patients demonstrated widespread impairments in the OCS in the Posterior Circulation 
Infarcts category than in the other categories.
conclusion: Overall, the results showed a much higher incidence of cognitive impair-
ment with the OCS than with the MMSE and demonstrated no false negatives for OCS 
vs MMSE. It is concluded that OCS is a sensitive screen tool for cognitive deficits after 
stroke. In particular, the OCS detects high incidences of stroke-specific cognitive impair-
ments, not detected by the MMSE, demonstrating the importance of cognitive profiling.
Keywords: stroke, cognitive assessment, Oxford cognitive screen, Mini-Mental state examination, cognitive 
screening 
inTrODUcTiOn
Stroke is the second most common cause of death and the third 
most common source of disability (1, 2). Its prevalence and inci-
dence increases with age representing the leading cause of disabil-
ity in the elderly (2). Patients with stroke have cognitive deficits in 
a very high proportion of cases [e.g., Ref. (1)], although variables 
estimates are reported. The differences are likely due to variability 
in sample characteristics, assessment methods, definitions of 
impairment, and time interval since stroke onset (1). As cognitive 
assessment is time consuming, physicians often use smart tools 
to assess cognitive impairment in stroke survivors that need little 
time but are often of limited use to highlight cognitive dysfunc-
tion, typically yielding relatively low-prevalence rates, below 
25% (3, 4). On the opposite, more detailed neuropsychological 
assessments of domain-specific cognitive impairments consume 
more time but are better at detecting cognitive impairment, 
highlighting higher occurrences, ranging from 35 to 92% (5–8). 
Language, spatial attention, memory, praxis, executive function, 
and speed of processing are the main impaired cognitive domains 
(5). Moreover, psychiatric comorbidities such as depression and 
delirium often occur after a stroke (9). Cognitive deficits interfere 
with rehabilitation and represent a negative prognostic factor 
(10, 11), impacting on activities of daily living, quality of life, and 
return to work (12).
Stroke guidelines recommend the importance of early cogni-
tive diagnosis in order to plan tailored rehabilitation programs 
(13). Tools, such as the Mini-Mental State Examination [MMSE; 
(14)] and the Montreal Cognitive Assessment [MoCA; (15)], are 
widely used as a practical solution to briefly assess cognition post-
stroke. However, these instruments were devised for evaluation 
of patients with dementia and only provide a “domain-general” 
cognitive score with a single cutoff for impairment. The present 
study describes the use of a newly devised instrument, the Oxford 
Cognitive Screen (OCS), against one of these two reference tools, 
namely the MMSE; in a parallel study, we examined the effective-
ness of the OCS against the MoCA (16).
Interest in using the MMSE as a comparison chiefly stems 
from its wide use; indeed, it is one of the most widely tests used 
in clinical practice. Early reviews emphasized the reliability and 
construct validity of the MMSE to capture moderate-to-severe 
cognitive impairment (17). However, the limits of the MMSE are 
also well-known particularly in the assessment of stroke patients 
(18, 19). In spite of this, the MMSE is still one of the instruments 
which is most widely used nowadays in clinical settings to detect 
global cognitive impairment in patients with stroke (20–30). In 
particular, it is used as a diagnostic index in the stroke units to 
plan the rehabilitation interventions as well as in the identifica-
tion of cognitive profiles after non-dementia cerebro-vascular 
events (21, 29, 31–33).
The key problem in using the MMSE to assess stroke sequelae 
is that it does not explicitly assess common post-stroke domain-
specific impairments such as neglect, executive function, 
apraxia, and aphasia. Indeed, performance on the MMSE can be 
confounded by co-occurring difficulties in these domains. For 
example, a patient with expressive aphasia will maximally score 4 
points (out of a maximum 30) as the large majority of tasks require 
spoken language. This would lead to a potential misclassifica-
tion of patients as “dementia” where there is a specific language 
impairment. Similarly, specific cognitive impairments may be 
“missed” in patients with stroke. This lack of specificity contrasts 
the indications of several clinical guidelines which emphasize the 
need to assess performance across different domains of cognition 
after stroke [e.g., Ref. (2, 34)].
The OCS was recently developed with the specific aim of 
describing the cognitive deficits after stroke (35); OCS was devised 
to be inclusive and un-confounded by aphasia and neglect. It can 
be administered within 15 min, can be delivered at the bedside, is 
easy to administer and score, can be used in relatively acute phase 
(after 3 days from onset) and provides a “snapshot” of a patient’s 
cognitive profile useful to define the rehabilitative program. The 
possibility to have separate cutoff for each of the tasks used allows 
obtaining a cognitive pinpointing strengths and weaknesses of 
individual stroke patients.
The scale consists of 10 tasks encompassing five cognitive 
domains: attention and executive function, language, memory, 
number processing, and praxis. Furthermore, it includes a brief 
evaluation of visual field defects. Administration is simple and 
brief (ca. 15 min) making it also suitable for immobilized patients. 
Demeyere et al. (16) provided initial data on a sample of stroke 
patients indicating the ability of the scale to detect differentiated 
profiles across the various domains and also reported a greater 
sensitivity of OCS over MoCA.
In order to assess whether this new instrument provides a 
sensitive and practical first line assessment supporting wider 
adoption, the present study aimed to compare the OCS with the 
MMSE in detecting cognitive symptoms after stroke, thereby 
providing further data on the sensitivity and specificity of the 
OCS in the identification of cognitive deficits in a relatively 
large sample of first stroke patients. We also examined OCS 
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performance as a function of subtypes of cerebral infarction 
[based on the Bamford classification; (36)] and clinical sever-
ity [based on the National Institutes of Health Stroke Scale, 
NIHSS; (37)].
MaTerials anD MeThODs
Patients
Fourteen different Italian rehabilitative centers participated 
in this study. In each center, the patients were consecutively 
recruited from February to October 2016 and selected based on 
the following inclusion and exclusion criteria.
– Inclusion criteria: Patients at first episode; both gender; aged 
from 18 to 90  years; distance from stroke onset within180 
days; patients who were able to give informed consent; ability 
to concentrate for a minimum of 20 min (as judged by the care 
team).
– Exclusion criteria: Patients with a previous stroke; the presence 
of premorbid psychiatric or neurological disease; distance 
from onset <72 h; patients unable to give informed consent; 
patients without ability to concentrate for <20 min (as judged 
by the care team).
The sample dimension was calculated through a power analysis 
carried out with the G*Power 3.1 program (finale sample tested 
n = 325 patients; see below for a description).
The research was approved by the Tuscany-South East Vast 
Area Ethical Committee (n. 376/2015); all patients signed the 
informed consent.
cognitive screening Tests
The OCS (35) assesses five cognitive domains: attention and 
executive function, language, memory, number processing, and 
praxis. Furthermore, visual field deficits are also assessed.
A brief description of tests according to each domain follows 
(in brackets the order of sub-test presentation):
•	 Language	domain:
 ◦ Picture naming (1): The patient is requested to name four 
pictures in order to assess the expressive language.
 ◦ Semantics (2): The patient has to point the picture asked, 
choosing between four pictures simultaneously shown.
 ◦ Sentence reading (5): One centrally aligned 15-word long 
sentence is presented and the participant is asked to read it 
aloud. The sentence is later used for an unanticipated verbal 
memory task.
•	 Memory	domain:
 ◦ Orientation (3): The participant is asked about which city 
is in, the time of the day, the month, and the year.
 ◦ Recall and recognition (10): The patient is asked to recall the 
sentence previously read in the “sentence reading task.” If 
the patient is unable to recall the sentence, a page with four 
options for each irregular word is shown. A further four 
multiple-choice questions are then given to address non-
verbal, episodic memory through task recall.
•	 Number	processing	domain:
 ◦ Number writing (6): The patient is asked to write down the 
numbers heard.
 ◦ Calculation task (7): The patient is required to make two 
additions and two subtractions.
•	 Attention	and	executive	function	domain:
 ◦ Broken hearts (8): A page with 150 semi-randomly posi-
tioned hearts (50 full hearts and 50 broken on the left and 
50 on the right) is presented. The task is to cancel out all 
complete hearts while not crossing out hearts broken on 
the left or on the right with a 3-min time limit.
 ◦ Trails task (11): Stimuli are pages with circles and squares 
of different sizes. The two baseline tasks require drawing a 
line between either circles or squares going down in size and 
alternating between circles and squares, again going down 
in size (largest square to largest circle to next largest square, 
etc.).
•	 Praxis	domain:
 ◦ Imitating meaningless gestures (9): This test requires to 
patient to mirror imitate, with their better hand, a series of 
meaningless hand and finger actions made by the exami-
ner.
•	 Visual	field	(4):	The	examiner	faces	the	participant	and	raises	
both hands, first to the participant’s upper visual fields, and 
then to the lower fields asking to wiggle the fingers of the left 
or right hand.
The OCS can be administered in about 15  min and can be 
delivered at the bedside, whenever necessary. The Italian version 
of the scale, with normative data on a sample of 20- to 80-year-old 
individuals, was used (38).
The MMSE is a widely used tool for cognitive assessment. As 
a domain-general cognitive screen, the MMSE ultimately returns 
a pass/fail judgment, based on a single overall score. The instru-
ment can be divided into two main sections: the first requires 
only verbal feedback and includes the evaluation of orientation, 
memory, and attention. The second part assesses the naming skills, 
to follow verbal and written commands, write spontaneously 
a sentence, and copy a complex polygon. Although the MMSE 
contains subsections, there are no sub-domain cutoffs. The total 
maximum score is 30 and the total time of administration is about 
10  min. Normative values, adjusted for age and education, are 
available for the Italian elderly population and the cutoff <22 was 
established for pathological performance (14).
The OCS and MMSE were presented on the same day; order 
of presentation of the two tests was counterbalanced on an ABAB 
basis for each rehabilitation center. Tests were administered in a 
quiet and comfortable setting.
clinical scales
The NIHSS was designed to evaluate stroke severity. It con-
sists of 11 items, the total score ranging from a minimum 
of 0 (normal neurological functioning) to a maximum of 42 
(severe neurological damage). The following categories are 
considered: minor stroke =  1–4, moderate =  5–15, moderate 
to severe = 16–20, severe = 21–42. The time of administration 
is about 5/8 min (37).
TaBle 3 | Number (and percentage) of patients who passed the cutoff for 
Mini-Mental State Examination (n = 208) but failed in one or more of the Oxford 
Cognitive Screen tests.
Domain Task n %
Language Picture naming 71 34.1
Semantics 10 4.8
Sentence reading 71 34.1
Memory Orientation 17 8.1
Recall and recognition 61 29.3
Episodic memory 65 31.2
Number Number writing 35 16.8
Calculation 76 36.5
Perception Visual field 23 11
Spatial attention Hearts cancelation 95 45.6
Space asymmetry 43 20.6
Object asymmetry 14 6.7
Praxis Imitation 33 15.8
Executive function Baseline score 77 37
Shifting score 65 31.2
TaBle 2 | Number and percentage of patients for whom Oxford Cognitive 
Screen tests could not be administered.
Domain Tasks n %
Language Picture naming 4 1.2
Semantics 3 0.9
Sentence reading 5 1.2
Memory Orientation 3 0.9
Recall and recognition 3 0.9
Episodic memory 3 0.9
Number Number writing 5 1.5
Calculation 3 0.9
Perception Visual field 5 1.5
Spatial attention Hearts cancelation 17 5.2
Space asymmetry 21 6.4
Object asymmetry 21 6.4
Praxis Imitation 5 1.5
Executive function Baseline score 28 8.6
Shifting score 26 8
TaBle 1 | Characteristics of the sample.
category no. of patients 
(325)
%
Gender Male
Female
178
147
54.7
45.2
Etiology Ischemic
Hemorrhagic
278
44
85.5
13.5
Lesion lateralization Unilateral left hemisphere
Unilateral right hemisphere
Bilateral/cerebellar
122
184
19
37.5
56.6
5.8
Vascular territory affected 
for ischemic patients:
Bamford classification
(n = 274)
TACI
LACI
PACI
POCI
58
76
91
54
17.8
23.3
28
16.6
Stroke severity:
NIHSS
Minor
Moderate
Moderate to severe
Severe
171
136
13
4
52.6
41.8
4
1.2
4
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The Bamford Classification (36) allows clustering patients 
with cerebral infarction according to some distinctive features, 
placing them into four groups: Lacunar Infarcts, Total Anterior 
Circulation Infarcts, Partial Anterior Circulation Infarcts, and 
Posterior Circulation Infarcts (POCI) on the basis of the signs 
and symptoms.
statistics
For descriptive purposes, we examined the percentage (%) of 
patients to whom the OCS could not be administered, as well 
as the % of patients falling in one or more domains of the scale.
In order to examine the significance of the association between 
different kinds of classification, we used Fisher’s exact test for cat-
egorical data when expected values in at least one cell was below 5. 
This was the case for the Bamford classification, OCS, and MMSE. 
Conversely, χ2 tests were used to examine contingency tables with 
expected values always above 5, as in the case of NIHSS values.
resUlTs
Over the 9  months of data collection, we recruited a total of 
325 patients (178 males and 147 females). The mean age was 
69.46  years (SD  =  12.53) while years of education averaged 
9.07 years (SD = 4.52). The average time from stroke was 33.9 days 
(SD = 41. 8). Demographic and clinical features of the sample are 
given in Table 1. Based on CT scan data 278 patients had ischemic 
and 44 hemorrhagic stroke etiologies. Unilateral lesions were 
found in 306 patients: 122 had left-hemisphere damage (LHD) 
and 184 right-hemisphere damage (RHD). Only 19 patients had 
bilateral (midline) or cerebellar lesions.
The OCS proved generally easy to administer and only for 
three patients (0.9%) the scale could not be given at all. In a few 
cases, some tests could not be administered (see Table  2); the 
main reasons for this were severe visual or motor impairment, 
fatigue or inability to understand the instructions due to severe 
global aphasia. The MMSE could not be administered to six 
patients.
About a third of patients (n = 115; 35.3%) had a performance 
lower than the cutoff (<22) (14) on the MMSE, whereas 91.6% 
(n = 295) were impaired in at least one OCS domain (Table 3), 
indicating higher incidences of impairment for the OCS than 
MMSE (Fisher’s exact p <  0.0001). More than 80% of patients 
(n = 263; 81.6%) showed an impairment in two or more cognitive 
domains of the OCS. Using the MMSE as a standard of clinical 
practice, the comparative sensitivity of OCS was 100%, indicating 
that no patients had an impairment in MMSE but not in OCS. 
Infact, 180 patients with cognitive deficit were detected as posi-
tive to OCS but not to MMSE, indicating that OCS did not show 
false negative.
Out of the 208 patients with normal MMSE performance (i.e., 
a score of at least 22), 180 showed impaired performance in at 
least one domain of the OCS (Table 3). Note the high proportion 
FigUre 1 | Incidence of impairment at Mini-Mental State Examination (MMSE) and Oxford Cognitive Screen (OCS) (at least one domain) as a function of NIHSS 
severity (minor = NIHSS 1–4, moderate = 5–15, moderate-severe = 16–20). Too few patients were in the severe NIHSS category to allow for reliable comparisons.
5
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of patients (about one-third or more) with impaired performance 
in picture naming and sentence reading (language domain), 
calculation (number processing domain), recall and recognition 
and episodic memory tests (memory), and hearts cancelation 
(attention domain). Only 27 patients were not impaired in both 
cognitive scales.
Most patients (n = 266; 82.1%) had a motor, sensory, or cogni-
tive deficit on the NIHSS (proportion of patients as a function of 
stroke severity is presented in Table 1). There was a weak, but 
significant, inverse correlation between the severity of the NIHSS 
and MMSE corrected score (r = −0.186, p = 0.001). Incidence 
of impairment on the OCS was significantly higher than that in 
the MMSE in the minor (χ2(1) = 41.18, p < 0.0001) and moderate 
(χ2(1) =  32.82, p <  0.0001) categories but not in the moderate-
severe category (χ2(1) = 1.16, p = 0.28; see Figure 1).
In relationship to the Bamford Classification, the frequency 
of impairments in OCS domains was higher than the MMSE 
impairments for all categories (all Fisher’s exact tests at least 
p < 0.01). When considering the number of domain impairments 
on OCS, fewer patients demonstrated widespread impairments 
(i.e., more than three domains) in the POCI category than in the 
other categories (see Figure 2).
With regards to lesion side, there were 37.5% (n = 122) patients 
with LHD and 56.6% (n = 184) patients with RHD. The remain-
ing patients had bilateral and/or cerebellar damage. Among LHD 
patients, 43.4% were deficient in the MMSE, while 91.8% were 
impaired in at least one OCS domain. Among RHD patients, 32% 
were deficient in the MMSE, while 90.2% were impaired in at least 
one OCS domain.
Incidence of impairments in the MMSE and in the different 
OCS domains/tests is reported in Table 4 separately for the overall 
sample, the LHD and RHD patients. LHD patients had higher fre-
quency of impairments in the language domain (sentence reading 
test) and in the memory domain (recall and recognition test). 
In the broken hearts test, a higher percentage of RHD patients 
showed inattention for left space while a higher percentage of 
LHD patients showed a higher percentage of right inattention for 
the right space. Finally, there was a trend for RHD patients to be 
more impaired in the shifting score (executive function domain). 
As for the MMSE, RHD patients were more frequently impaired 
than LHD patients.
DiscUssiOn
Our study examined the detection of cognitive symptoms after 
a first stroke by comparing two scales, the widely used MMSE, 
and a new instrument, the OCS. The results showed a much 
higher incidence of cognitive impairment with the OCS (91% 
at least one domain impairment) than with the MMSE (35%), 
and demonstrated no false negatives for OCS vs MMSE (giving 
OCS a comparative sensitivity of 100%). These data support 
recent reports on the under-detection of post-stroke cognitive 
impairments of MMSE (18, 39) and further highlight the short-
comings of using tests designed for dementia (16, 40) within a 
stroke population. In particular, in a parallel study we demon-
strated the greater sensitivity of the OCS scale over the MoCA 
scale, another instrument originally devised for the detection 
of dementia symptoms. In this respect, it may be noted that 
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FigUre 2 | Percentage of Oxford Cognitive Screen domain impairments for each of the four Bamford categories.
TaBle 4 | Percentage of patients obtaining a pathological score in the Mini-Mental State Examination (MMSE) and Oxford Cognitive Screen (OCS) tests as a function of 
lesion lateralization.
screen cognitive domain Task lateralization
Overall (%), n = 325 Unilateral left (%), n = 122 Unilateral right (%), n = 184 p-Value
MMSE Overall score Cutoff = 22 35.3 43.4 32 0.039
OCS Language Picture naming 43.6 47.5 40.7 0.156
Semantics 11.08 10.6 12.5 0.72
Sentence reading 49.8 57.3 45.1 0.019
Memory Orientation 21.8 22.1 22.8 1.000
Recall and recognition 47.0 56.5 42.9 0.013
Episodic memory 48.3 48.3 47.2 0.725
Number Number writing 36 40.1 34.2 0.223
Calculation 50.7 55.7 48.3 0.158
Perception Visual field 15.6 11.4 18.4 0.147
Spatial attention Hearts cancelation 55.6 50 60.3 0.121
Space asymmetry 31.3 28.6 35.3 0.316
Left inattention > 3 20 20.4 26.09 0.000
Right inattention < −3 14 12.3 10.3 0.018
Object asymmetry 6.7 7.3 4.8 0.456
Left inattention > 2 10.1 7.3 12.5 0.122
Right inattention < −2 6.7 6.5 4.8 0.332
Praxis Imitation 28.3 29.5 27.7 0.697
Executive function Baseline score 34.7 36.07 34.2 0.71
Shifting score 32.3 25.4 36.9 0.076
there is some indication of a greater sensitivity of MoCA over 
the MMSE (20, 39, 41); however, there is also counter-evidence 
pointing to a substantial equivalence between these two instru-
ments [(42); for a review see Ref. (43)]. This is particularly the 
case when cutoffs adjusted for age and schooling (21) are used 
(22) as in the present study. Overall, it appears that cognitive 
deficits after stroke are detected more effectively by a tool 
(OCS) selectively devised to capture deficits after stroke than 
by tools originally devised for dementia, such as MMSE and 
MoCA.
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The detection of discrepancy between OCS and MMSE was 
particularly strong for patients with milder stroke, i.e., in the lower 
NIHSS range. For patients in the moderate-to-severe category, 
there was no longer a difference between the cognitive screens, 
as almost all patients had severe cognitive impairments, likely to 
be detected by any type of cognitive screening. This finding is in 
keeping with previous observations that MMSE is not sensitive to 
mild cognitive deficits [e.g., (44)].
Over 80% of patients showed an impairment in more than 
one cognitive domain on the OCS, demonstrating the impor-
tance of cognitive profiling (45). A recent study highlighted that 
the MMSE was only able to detect much lower frequencies of 
cognitive dysfunction [24–50% and 6–31%, respectively; (1)]. 
The OCS detected high incidences of stroke-specific cognitive 
impairments, not detected by the MMSE: e.g., neglect was present 
in 31% of the patients unimpaired on the MMSE. Similarly, 49% 
of patients failed in the sentence reading task (Table 4). These 
stroke-specific problems are not detected in the MMSE as they 
are considered to be unimpaired within a dementia profile; so, 
they are not assessed in this screen. Given that such stroke-
specific deficits may be targeted by specific interventions (e.g., 
occupational therapy for apraxia, scanning or prism therapies for 
neglect, specific communication therapies for different language 
impairments, etc.), domain-level cognitive profiling is likely to be 
effective for planning individually tailored interventions.
Considering the Bamford classification, fewer patients pre-
sented widespread cognitive impairments (i.e., more than three 
OCS domains) in the POCI category. It is known that POCI 
stroke infarcts do not affect subcortical structures involving the 
larger attention networks. This is in line with other studies that 
indicate that patients with lesions in the vertebro-basilar territory 
have clinical features that make them different from patients with 
lesions in the cortical or subcortical areas (46). Infact, the impair-
ment of these posterior areas most frequently cause motor deficits, 
articulatory speech difficulties, dysphagia, vertigo, nausea or vom-
iting, facial palsies, or lower cranial nerve deficits (46). In contrast, 
strokes in these posterior areas result in less disruption of brain 
regions involved in cognition (47). Thus, patients with ischemia in 
these areas typically show better cognitive outcomes and cognitive 
deficits, such as aphasia and neglect, are infrequent (47).
Finally, some features of the OCS scale that indicate its feasibil-
ity for clinical use on post-stroke patients should be emphasized. 
The scale allows detailed screening of the cognitive domains that 
are compromised following stroke, through the separate assess-
ment of memory, language, number cognition, praxis, executive 
functions, and attention; visualization of patient’s strengths and 
weaknesses is made possible through reference to separate cutoffs 
for single subtests. Administration is compatible with the pres-
ence of severe language impairments as OCS includes items that 
do not require language-based answers (e.g., the patient has to 
indicate the answer among different visual alternatives); similarly, 
the influence of left unilateral spatial neglect is minimized by 
arranging targets vertically whenever appropriate. Finally, the 
administration is generally short (usually within 15 min) and well 
suited to daily clinical practice, including the patient’s bedside. 
The experience with patients in the present study confirmed these 
general comments. Only for three patients (i.e., less than 1%) we 
could not administer the OCS; in a limited number of cases, 
individual subtests could not be given (this ranged from 0.9 to 
8.6% depending on the sub-test).
conclusion
Results indicate that OCS presents a sensitive screening procedure 
for cognitive deficits after stroke. In particular, the OCS detects 
high incidences of stroke-specific cognitive impairments, not 
detected by the MMSE, demonstrating the importance of cognitive 
profiling. In view of the wide use of MMSE, we propose that this 
conclusion calls for a substantial revision of the clinical standards 
for the screening procedures of cognitive deficits after stroke.
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